Adeoye Olukotun
Director/Board Member chez ARROWHEAD PHARMACEUTICALS, INC.
Fortune : 653 629 $ au 31/03/2024
Profil
Adeoye Y.
Olukotun founded VIA Pharmaceuticals, Inc. in 2004, where he worked as Chief Medical Officer from 2004 to 2008 and CR Strategies LLC in 2000, where he is working as Chief Executive Officer from 2000.
Dr. Olukotun also currently works at Electrophysiology Research Foundation, as Chief Executive Officer & Trustee, Arrowhead Pharmaceuticals, Inc., as Independent Director from 2020, and Tonix Pharmaceuticals Holding Corp., as Independent Director from 2018.
Dr. Olukotun also formerly worked at Abcentra, Inc., as Chief Executive Officer from 2006 to 2013, Epigen Pharmaceuticals, Inc., as President & Chief Executive Officer from 2014 to 2018, Cardio Vax LLC, as Vice Chairman from 2012 to 2016, BioClinica, Inc., as Independent Director from 2011 to 2013, Nordion (Canada), Inc., as Director in 2010, Neusentis, Inc., as Director, SemBioSys Genetics, Inc., as Director in 2007, Milestone Pharmaceuticals, Inc., as Director, MDS Nordion, Inc., as Director, BioMedical Systems Corp., as Director, D&R Greenway Land Trust, Inc., as Director, Diadexus, Inc., as Independent Director from 2013 to 2015, Genesis Unicorn Capital Corp., as Director, Chief Executive & Technology Officer, Bristol Myers Squibb Co., as Vice President, Mallinckrodt, Inc.(Old), as Vice President-Medical & Regulatory Affairs from 1996 to 2000, and Esperion Therapeutics, Inc., as Chief Medical Officer & SVP-Regulatory Affairs from 2001 to 2004.
Dr. Olukotun received his doctorate degree in 1973 from Albert Einstein College of Medicine, Inc., graduate degree in 1983 from Harvard T.H.
Chan School of Public Health, and undergraduate degree in 1969 from UNC School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/01/2024 | 22 854 ( 0,02% ) | 653 624 $ | 31/03/2024 | |
| 27/03/2024 | 27 ( 0,00% ) | 5 $ | 31/03/2024 |
Postes actifs de Adeoye Olukotun
| Sociétés | Poste | Début |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Director/Board Member | 05/09/2018 |
| ARROWHEAD PHARMACEUTICALS, INC. | Director/Board Member | 01/09/2020 |
Electrophysiology Research Foundation
 Electrophysiology Research Foundation Miscellaneous Commercial ServicesCommercial Services Electrophysiology Research Foundation operates as a charitable non-profit organization devoted solely to research and education in cardiac electrophysiology. It engages in the conducting research studies in the field of cardiac pharmacology, cardiac lectrophysiology, arrhythmia ablation, implantable pacemakers, and implantable cardioverter-defibrillators. The firm conducts and coordinates multicenter clinical trials, and basic research in cardiac electrophysiology and cardiac pacing. The company was founded by Sanjeev Saksena on August 2, 1982 and is headquartered in Warren, NJ. | Chief Executive Officer | - |
| CR Strategies LLC | Chief Executive Officer | 01/03/2000 |
Anciens postes connus de Adeoye Olukotun
| Sociétés | Poste | Fin |
|---|---|---|
Epigen Pharmaceuticals, Inc.
 Epigen Pharmaceuticals, Inc. BiotechnologyHealth Technology Epigen Pharmaceuticals, Inc. develops cardiac reperfusion therapies. The private company is based in Princeton. | Chief Executive Officer | 01/01/2018 |
| Cardio Vax LLC | Chief Executive Officer | 01/01/2012 |
| DIADEXUS, INC. | Director/Board Member | 09/06/2015 |
| BIOCLINICA INC | Director/Board Member | 01/01/2013 |
| VIA PHARMACEUTICALS, INC. | Founder | 01/01/2008 |
Formation de Adeoye Olukotun
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
| UNC School of Law | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| VIA PHARMACEUTICALS, INC. | Health Technology |
| TONIX PHARMACEUTICALS HOLDING CORP. | Health Technology |
| Entreprise privées | 15 |
|---|---|
Mallinckrodt, Inc.(Old)
 Mallinckrodt, Inc.(Old) Medical SpecialtiesHealth Technology Mallinckrodt, Inc. developed manufactured and marketed medical products for hospitals. It provided specialty healthcare products for diagnostic imaging, respiratory care and pain relief. The firm sold its products to hospitals, alternate care sites, drug manufacturers and clinical laboratories. The company was founded in 1867 and was headquartered in Hazelwood, MO. | Health Technology |
BioClinica, Inc.
 BioClinica, Inc. Medical/Nursing ServicesHealth Services BioClinica, Inc. engages in the provision of integrated and technology-enhanced clinical trial management services. It offers research network, eclinical solutions, randomization and trial supply management, medical imaging, and cardiac safety. The company was founded in 1990 and is headquartered in Princeton, NJ. | Health Services |
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
Neusentis, Inc.
 Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Health Technology |
SemBioSys Genetics, Inc.
 SemBioSys Genetics, Inc. BiotechnologyHealth Technology SemBioSys Genetics, Inc. operates as a plant-based technology development company, which engages in the manufacturing technology platforms to develop, manufacture and commercialize healthy living, animal health and pharmaceutical products. It offers proteins, functional food and nutritional products. The company was founded by Maurice Moloney on April 25, 1994 and is headquartered in Calgary, Canada. | Health Technology |
MDS Nordion, Inc.
 MDS Nordion, Inc. Pharmaceuticals: OtherHealth Technology MDS Nordion, Inc. use to export medical isotopes, radio therapeutics and related technologies. Its products and services were used in hospitals, clinics, large medical supply companies, biotechnology, pharmaceutical companies, food processors and manufacturers. The company was founded in 1946 and was headquartered in Ottawa, Canada. | Health Technology |
BioMedical Systems Corp.
 BioMedical Systems Corp. Medical/Nursing ServicesHealth Services BioMedical Systems Corp. provides centralized diagnostic services to pharmaceutical and medical industries. It offers cardiac modalities, including digital 12-lead electrocardiogram (ECG), TQT/intensive studies, Holter monitoring, ambulatory blood pressure monitoring, and ECG stress testing. The firm also centralizes pulmonary function testing in pharmaceutical and medical device clinical trials for the modalities, including spirometry, peak flow with eDiary, challenge testing, pulse oximetry, nitric oxide, and DLco/lung volumes. The company was founded by W. Raymond Barrett in 1975 and is headquartered in St. Louis, MO. | Health Services |
D&R Greenway Land Trust, Inc.
 D&R Greenway Land Trust, Inc. Miscellaneous Commercial ServicesCommercial Services D&R Greenway Land Trust is a non-profit organization which works to preserve and protect a permanent network of natural lands and open spaces in central New Jersey. The company was founded by Jim Amon, Rosemary Blair, Dennis Davidson, Sam Hamill, and Bob Johnston in 1989 and is headquartered in Princeton, NJ. | Commercial Services |
| CR Strategies LLC | |
Abcentra, Inc.
 Abcentra, Inc. Miscellaneous Commercial ServicesCommercial Services Abcentra, Inc. is an American clinical-stage biopharmaceutical company that specializes in developing novel antibody therapies for inflammatory diseases, with a particular focus on cardiovascular disease. The private company's patented technology allows for the targeting of oxidized lipoproteins and associated inflammatory responses. Abcentra's pipeline focuses on patient populations with high-risk of cardiometabolic complications that are exacerbated by chronic inflammation, including patients with inflammatory diseases and patients with residual inflammation. The company's lead compound, orticumab, is a novel monoclonal antibody that blocks inflammation from oxidized low-density lipoprotein and is slated to begin a phase 2 study later this year. Kevin B. Bacon has been the CEO of the company since 2020. | Commercial Services |
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
| Cardio Vax LLC | |
Electrophysiology Research Foundation
Electrophysiology Research Foundation Miscellaneous Commercial ServicesCommercial Services Electrophysiology Research Foundation operates as a charitable non-profit organization devoted solely to research and education in cardiac electrophysiology. It engages in the conducting research studies in the field of cardiac pharmacology, cardiac lectrophysiology, arrhythmia ablation, implantable pacemakers, and implantable cardioverter-defibrillators. The firm conducts and coordinates multicenter clinical trials, and basic research in cardiac electrophysiology and cardiac pacing. The company was founded by Sanjeev Saksena on August 2, 1982 and is headquartered in Warren, NJ. | Commercial Services |
Epigen Pharmaceuticals, Inc.
Epigen Pharmaceuticals, Inc. BiotechnologyHealth Technology Epigen Pharmaceuticals, Inc. develops cardiac reperfusion therapies. The private company is based in Princeton. | Health Technology |
Genesis Unicorn Capital Corp.
 Genesis Unicorn Capital Corp. Financial ConglomeratesFinance Genesis Unicorn Capital Corp. is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 23, 2021 and is headquartered in Princeton, NJ. | Finance |
